Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol : the Losartan Intervention For Endpoint reduction in hypertension study.

Keyword

Aged

Aged; 80 and over

Angiotensin II Type 1 Receptor Blockers/*therapeutic use

Antihypertensive Agents/*therapeutic use

Atenolol/*therapeutic use

Atrial Fibrillation/complications

Comorbidity

Diabetes Complications

Double-Blind Method

Female

Humans

Hypercholesterolemia/complications

Hypertension/*complications/drug therapy

Hypertrophy; Left Ventricular/*complications

Incidence

Losartan/*therapeutic use

Male

Middle Aged

Severity of Illness Index

Stroke/epidemiology/*prevention & control

Treatment Outcome

Publication and Content Type

ref (subject category)

art (subject category)